<PAGE>
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13D-102)
INFORMATION STATEMENT PURSUANT TO RULES 13D-1 AND 13D-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
ALGOS PHARMACEUTICAL CORPORATION
(NAME OF ISSUER)
COMMON STOCK, PAR VALUE $.01 PER SHARE
(TITLE OF CLASS OF SECURITIES)
015869 10 0
(CUSIP NUMBER)
Page 1 of 5 pages
<PAGE>
<PAGE>
13G
CUSIP NO. 015869 10 0
-----------
1. NAME OF REPORTING PERSON:
KAREN LYLE
-------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(A) [ ]
(B) [ ]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION:
UNITED STATES CITIZEN
-------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
5. SOLE VOTING POWER:
1,742,654
-------------------------------------------------------------
6. SHARED VOTING POWER:
-0-
-------------------------------------------------------------
7. SOLE DISPOSITIVE POWER:
1,742,654
-------------------------------------------------------------
8. SHARED DISPOSITIVE POWER:
-0-
-------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON:
1,742,654
-------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES:
[ ]
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9: 10.9%
-------------------------------------------------------------
12. TYPE OF REPORTING PERSON:
IN
-------------------------------------------------------------
Page 2 of 5 pages
<PAGE>
<PAGE>
Item 1.
(a) Name of Issuer: Algos Pharmaceutical Corporation
(b) Address of Issuer's Principal Executive Offices:
Collingwood Plaza, 4900 Route 33
Neptune, New Jersey 07753-6804
Item 2.
(a) Name of Person Filing: Karen Lyle
(b) Address of Principal Business Office:
Algos Pharmaceutical Corporation
Collingwood Plaza, 4900 Route 33
Neptune, New Jersey 07753-6804
(c) Citizenship: United States
(d) Title of Class of Securities:
Common Stock, $.01 par value
(e) CUSIP Number: 015869 10 0
Item 3. Not applicable.
Item 4. Ownership
(a) Amount Beneficially Owned: 1,742,654
(b) Percent of Class: 10.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
1,742,654
--------------------------------------------
(ii) shared power to vote or to direct the vote:
-0-
--------------------------------------------
(iii) sole power to dispose or to direct the
disposition of:
1,742,654
-------------------------------------------
(iv) shared power to dispose or to direct the
disposition of:
-0-
-------------------------------------------
Page 3 of 5 pages
<PAGE>
<PAGE>
Item 5. Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of
Another Person:
The 1,742,654 shares reported by Mrs. Lyle, includes 74,700
shares of common stock and options to purchase 300,500 shares
owned directly by John Lyle, husband of Mrs. Lyle, and 38
shares owned directly by Mrs. Lyle's son, as to which Mrs.
Lyle disclaims beneficial ownership.
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the
Parent Holding Company:
Not applicable.
Item 8. Identification and Classification of Members of the
Group:
Not applicable.
Item 9. Notice of Dissolution of Group:
Not applicable.
Item 10. Certification:
Not applicable.
Page 4 of 5 pages
<PAGE>
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: February 13, 1998
/s/ Karen Lyle
------------------------------
Karen Lyle
Page 5 of 5 pages
